Change from propylthiouracil to carbimazole proves fatal.
Burt
M G
MG
Waikato Clinical School, Department of Medicine, University of Auckland, Hamilton.
Conaglen
J V
JV
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced*; D013956:Antithyroid Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001228:Aspergillosis / Q000209:etiology; D002231:Carbimazole / Q000008:administration & dosage* / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008172:Lung Diseases, Fungal / Q000209:etiology; D009520:New Zealand; D011441:Propylthiouracil / Q000008:administration & dosage*; D012307:Risk Factors
D013956:Antithyroid Agents; D011441:Propylthiouracil; D002231:Carbimazole